The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT00327691




Registration number
NCT00327691
Ethics application status
Date submitted
16/05/2006
Date registered
18/05/2006
Date last updated
3/05/2007

Titles & IDs
Public title
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
Scientific title
The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD
Secondary ID [1] 0 0
A2581136
Secondary ID [2] 0 0
0981-117
Universal Trial Number (UTN)
Trial acronym
TNT
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cardiovascular Disease 0 0
Cerebrovascular Accident 0 0
Coronary Heart Disease 0 0
Condition category
Condition code
Stroke 0 0 0 0
Haemorrhagic
Stroke 0 0 0 0
Ischaemic
Cardiovascular 0 0 0 0
Coronary heart disease
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Atorvastatin

Treatment: Drugs: Atorvastatin


Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
The primary outcome is the time to occurrence of a major
Timepoint [1] 0 0
Primary outcome [2] 0 0
cardiovascular event, defined as the composite outcome of the
Timepoint [2] 0 0
Primary outcome [3] 0 0
following clinical endpoints
Timepoint [3] 0 0
Primary outcome [4] 0 0
CHD death
Timepoint [4] 0 0
Primary outcome [5] 0 0
Non-fatal/Non-procedure related MI
Timepoint [5] 0 0
Primary outcome [6] 0 0
Resuscitated cardiac arrest or fatal/non-fatal stroke
Timepoint [6] 0 0
Secondary outcome [1] 0 0
The occurrence of the following clinical events
Timepoint [1] 0 0
Secondary outcome [2] 0 0
Major coronary event (CHD death, non fatal myocardial infarction or resuscitated cardiac arrest)
Timepoint [2] 0 0
Secondary outcome [3] 0 0
any coronary event (major coronary event or CABG
Timepoint [3] 0 0
Secondary outcome [4] 0 0
PTCA, other revascularization procedure, procedure-related myocardial infarction, or documented angina)
Timepoint [4] 0 0
Secondary outcome [5] 0 0
cerebrovascular event (fatal or non fatal stroke, TIA)
Timepoint [5] 0 0
Secondary outcome [6] 0 0
peripheral vascular disease; hospitalization with primary diagnosis' of CHF
Timepoint [6] 0 0
Secondary outcome [7] 0 0
any cardiovascular event (any of the above); and all-cause mortality.
Timepoint [7] 0 0

Eligibility
Key inclusion criteria
Men and women age 35-75 who have evident CHD
Minimum age
35 Years
Maximum age
75 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Known hypersensitivity to HMG CO-A reductase therapy, liver disease, evidence of secondary
hyperlipidemia

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC,WA
Recruitment hospital [1] 0 0
Pfizer Investigational Site - St. Leonards
Recruitment hospital [2] 0 0
Pfizer Investigational Site - Auchenflower
Recruitment hospital [3] 0 0
Pfizer Investigational Site - Brisbane
Recruitment hospital [4] 0 0
Pfizer Investigational Site - Chermside
Recruitment hospital [5] 0 0
Pfizer Investigational Site - Greenslopes
Recruitment hospital [6] 0 0
Pfizer Investigational Site - Herston
Recruitment hospital [7] 0 0
Pfizer Investigational Site - Milton
Recruitment hospital [8] 0 0
Pfizer Investigational Site - Adelaide
Recruitment hospital [9] 0 0
Pfizer Investigational Site - Bedford Park
Recruitment hospital [10] 0 0
Pfizer Investigational Site - Hobart
Recruitment hospital [11] 0 0
Pfizer Investigational Site - Clayton
Recruitment hospital [12] 0 0
Pfizer Investigational Site - Parkville
Recruitment hospital [13] 0 0
Pfizer Investigational Site - Prahran
Recruitment hospital [14] 0 0
Pfizer Investigational Site - Nedlands
Recruitment postcode(s) [1] 0 0
2065 - St. Leonards
Recruitment postcode(s) [2] 0 0
4066 - Auchenflower
Recruitment postcode(s) [3] 0 0
4029 - Brisbane
Recruitment postcode(s) [4] 0 0
4032 - Chermside
Recruitment postcode(s) [5] 0 0
4130 - Greenslopes
Recruitment postcode(s) [6] 0 0
4029 - Herston
Recruitment postcode(s) [7] 0 0
4064 - Milton
Recruitment postcode(s) [8] 0 0
5000 - Adelaide
Recruitment postcode(s) [9] 0 0
5042 - Bedford Park
Recruitment postcode(s) [10] 0 0
7000 - Hobart
Recruitment postcode(s) [11] 0 0
3168 - Clayton
Recruitment postcode(s) [12] 0 0
3050 - Parkville
Recruitment postcode(s) [13] 0 0
3181 - Prahran
Recruitment postcode(s) [14] 0 0
6009 - Nedlands
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Connecticut
Country [6] 0 0
United States of America
State/province [6] 0 0
Delaware
Country [7] 0 0
United States of America
State/province [7] 0 0
District of Columbia
Country [8] 0 0
United States of America
State/province [8] 0 0
Florida
Country [9] 0 0
United States of America
State/province [9] 0 0
Georgia
Country [10] 0 0
United States of America
State/province [10] 0 0
Illinois
Country [11] 0 0
United States of America
State/province [11] 0 0
Indiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Iowa
Country [13] 0 0
United States of America
State/province [13] 0 0
Kansas
Country [14] 0 0
United States of America
State/province [14] 0 0
Kentucky
Country [15] 0 0
United States of America
State/province [15] 0 0
Louisiana
Country [16] 0 0
United States of America
State/province [16] 0 0
Maine
Country [17] 0 0
United States of America
State/province [17] 0 0
Maryland
Country [18] 0 0
United States of America
State/province [18] 0 0
Massachusetts
Country [19] 0 0
United States of America
State/province [19] 0 0
Michigan
Country [20] 0 0
United States of America
State/province [20] 0 0
Minnesota
Country [21] 0 0
United States of America
State/province [21] 0 0
Missouri
Country [22] 0 0
United States of America
State/province [22] 0 0
Nebraska
Country [23] 0 0
United States of America
State/province [23] 0 0
New Hampshire
Country [24] 0 0
United States of America
State/province [24] 0 0
New Jersey
Country [25] 0 0
United States of America
State/province [25] 0 0
New York
Country [26] 0 0
United States of America
State/province [26] 0 0
North Carolina
Country [27] 0 0
United States of America
State/province [27] 0 0
Ohio
Country [28] 0 0
United States of America
State/province [28] 0 0
Oklahoma
Country [29] 0 0
United States of America
State/province [29] 0 0
Oregon
Country [30] 0 0
United States of America
State/province [30] 0 0
Pennsylvania
Country [31] 0 0
United States of America
State/province [31] 0 0
Rhode Island
Country [32] 0 0
United States of America
State/province [32] 0 0
South Carolina
Country [33] 0 0
United States of America
State/province [33] 0 0
South Dakota
Country [34] 0 0
United States of America
State/province [34] 0 0
Tennessee
Country [35] 0 0
United States of America
State/province [35] 0 0
Texas
Country [36] 0 0
United States of America
State/province [36] 0 0
Utah
Country [37] 0 0
United States of America
State/province [37] 0 0
Vermont
Country [38] 0 0
United States of America
State/province [38] 0 0
Virginia
Country [39] 0 0
United States of America
State/province [39] 0 0
Washington
Country [40] 0 0
United States of America
State/province [40] 0 0
Wisconsin
Country [41] 0 0
Austria
State/province [41] 0 0
Feldkirch
Country [42] 0 0
Austria
State/province [42] 0 0
Oberpullendorf
Country [43] 0 0
Austria
State/province [43] 0 0
Wien
Country [44] 0 0
Belgium
State/province [44] 0 0
Aalst
Country [45] 0 0
Belgium
State/province [45] 0 0
Antwerpen
Country [46] 0 0
Belgium
State/province [46] 0 0
Genk
Country [47] 0 0
Belgium
State/province [47] 0 0
Godinne
Country [48] 0 0
Belgium
State/province [48] 0 0
Leuven
Country [49] 0 0
Belgium
State/province [49] 0 0
Lommel
Country [50] 0 0
Belgium
State/province [50] 0 0
Neerpelt
Country [51] 0 0
Canada
State/province [51] 0 0
Alberta
Country [52] 0 0
Canada
State/province [52] 0 0
British Columbia
Country [53] 0 0
Canada
State/province [53] 0 0
Manitoba
Country [54] 0 0
Canada
State/province [54] 0 0
Newfoundland and Labrador
Country [55] 0 0
Canada
State/province [55] 0 0
Nova Scotia
Country [56] 0 0
Canada
State/province [56] 0 0
Ontario
Country [57] 0 0
Canada
State/province [57] 0 0
Quebec
Country [58] 0 0
France
State/province [58] 0 0
Cedex
Country [59] 0 0
France
State/province [59] 0 0
Agen
Country [60] 0 0
France
State/province [60] 0 0
Bordeaux
Country [61] 0 0
France
State/province [61] 0 0
Brest
Country [62] 0 0
France
State/province [62] 0 0
Clermont-ferrand
Country [63] 0 0
France
State/province [63] 0 0
Lyon
Country [64] 0 0
France
State/province [64] 0 0
Marseille
Country [65] 0 0
France
State/province [65] 0 0
Paris CEDEX 05
Country [66] 0 0
France
State/province [66] 0 0
Rennes
Country [67] 0 0
France
State/province [67] 0 0
Roubaix Cdx
Country [68] 0 0
France
State/province [68] 0 0
Strasbourg
Country [69] 0 0
France
State/province [69] 0 0
Toulouse
Country [70] 0 0
Germany
State/province [70] 0 0
Berlin
Country [71] 0 0
Germany
State/province [71] 0 0
Essen
Country [72] 0 0
Germany
State/province [72] 0 0
Hamburg
Country [73] 0 0
Germany
State/province [73] 0 0
Schwerte
Country [74] 0 0
Germany
State/province [74] 0 0
Tostedt
Country [75] 0 0
Germany
State/province [75] 0 0
Wurzburg
Country [76] 0 0
Ireland
State/province [76] 0 0
Cork
Country [77] 0 0
Ireland
State/province [77] 0 0
Dublin
Country [78] 0 0
Italy
State/province [78] 0 0
Bologna
Country [79] 0 0
Italy
State/province [79] 0 0
Cuneo
Country [80] 0 0
Italy
State/province [80] 0 0
Firenze
Country [81] 0 0
Italy
State/province [81] 0 0
Napoli
Country [82] 0 0
Italy
State/province [82] 0 0
Rome
Country [83] 0 0
Italy
State/province [83] 0 0
Udine
Country [84] 0 0
Netherlands
State/province [84] 0 0
's-Hertogenbosch
Country [85] 0 0
Netherlands
State/province [85] 0 0
Alkmaar
Country [86] 0 0
Netherlands
State/province [86] 0 0
Amersfoort
Country [87] 0 0
Netherlands
State/province [87] 0 0
Amsterdam
Country [88] 0 0
Netherlands
State/province [88] 0 0
Breda
Country [89] 0 0
Netherlands
State/province [89] 0 0
Eindhoven
Country [90] 0 0
Netherlands
State/province [90] 0 0
Enschede
Country [91] 0 0
Netherlands
State/province [91] 0 0
Groningen
Country [92] 0 0
Netherlands
State/province [92] 0 0
Leiden
Country [93] 0 0
Netherlands
State/province [93] 0 0
Nieuwegein
Country [94] 0 0
Netherlands
State/province [94] 0 0
Nijmegen
Country [95] 0 0
Netherlands
State/province [95] 0 0
Zwolle
Country [96] 0 0
South Africa
State/province [96] 0 0
Gauteng
Country [97] 0 0
South Africa
State/province [97] 0 0
Bloemfontein
Country [98] 0 0
South Africa
State/province [98] 0 0
Cape Town
Country [99] 0 0
South Africa
State/province [99] 0 0
Parow
Country [100] 0 0
Spain
State/province [100] 0 0
Barcelona
Country [101] 0 0
Spain
State/province [101] 0 0
Cordoba
Country [102] 0 0
Spain
State/province [102] 0 0
Madrid
Country [103] 0 0
Spain
State/province [103] 0 0
San Sebastian
Country [104] 0 0
Spain
State/province [104] 0 0
Santiago de Compostela
Country [105] 0 0
Spain
State/province [105] 0 0
Sevilla
Country [106] 0 0
Spain
State/province [106] 0 0
Valladolid
Country [107] 0 0
Spain
State/province [107] 0 0
Zaragoza
Country [108] 0 0
Switzerland
State/province [108] 0 0
Bern
Country [109] 0 0
Switzerland
State/province [109] 0 0
Geneve 14
Country [110] 0 0
Switzerland
State/province [110] 0 0
Lausanne
Country [111] 0 0
Switzerland
State/province [111] 0 0
Lugano
Country [112] 0 0
Switzerland
State/province [112] 0 0
St Gallen
Country [113] 0 0
United Kingdom
State/province [113] 0 0
Essex
Country [114] 0 0
United Kingdom
State/province [114] 0 0
Greater London
Country [115] 0 0
United Kingdom
State/province [115] 0 0
Hampshire
Country [116] 0 0
United Kingdom
State/province [116] 0 0
Kent
Country [117] 0 0
United Kingdom
State/province [117] 0 0
Lancashire
Country [118] 0 0
United Kingdom
State/province [118] 0 0
Leicestershire
Country [119] 0 0
United Kingdom
State/province [119] 0 0
Middlesex
Country [120] 0 0
United Kingdom
State/province [120] 0 0
West Midlands
Country [121] 0 0
United Kingdom
State/province [121] 0 0
Wiltshire
Country [122] 0 0
United Kingdom
State/province [122] 0 0
Barnet
Country [123] 0 0
United Kingdom
State/province [123] 0 0
Glasgow
Country [124] 0 0
United Kingdom
State/province [124] 0 0
London
Country [125] 0 0
United Kingdom
State/province [125] 0 0
Paisley
Country [126] 0 0
State/province [126] 0 0

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Pfizer
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The primary objective of this study is to determine the degree of additional reduction in
cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently
accepted minimum target level for patients with pre-existing CHD. Secondary objectives
include the safety profile of this treatment strategy, its cost-effectiveness, effect on
other atherosclerotic-related events and procedures, and total mortality.
Trial website
https://clinicaltrials.gov/ct2/show/NCT00327691
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Pfizer CT.gov Call Center
Address 0 0
Pfizer
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT00327691